Willing and able? Provision of medication for abortion by future internists

Eleanor Schwarz, Anne Luetkemeyer, Diana Greene Foster, Tracy A. Weitz, Deborah Lindes, Felicia H. Stewart

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The development of medications such as mifepristone (RU486) has created the opportunity to introduce medication abortion as a component of office practice. Two hundred twelve residents training in internal medicine, family practice, and gynecology at 11 residency programs completed anonymous surveys assessing willingness to provide medication for abortion and perceived barriers to future provision of mifepristone. Residents training in internal medicine knew less about mifepristone and preabortion screening than other primary care trainees. Forty-two percent of internists, 84% of family practitioners, and 83% of gynecologists were willing to prescribe mifepristone (p < .001). Many internists were concerned about lacking adequate "backup" access to vacuum aspiration services (84% of internists, 74% of family practitioners, 35% of gynecologists; p < .001). In multivariable analysis, the training-related factors most predictive of whether an internist was willing to provide medication for abortion were feeling that mifepristone is very safe, abortion services are needed by the patients served, knowing to check an ultrasound before inducing abortion, and having no concern of how to manage bleeding or of lacking adequate backup should vacuum aspiration be needed. Many (42%) future internists are willing to provide mifepristone, but most lack adequate knowledge of mifepristone and preabortion screening. As access to abortion services is limited in many U.S. counties, internists who are willing to provide mifepristone should be offered the necessary training to do so safely.

Original languageEnglish (US)
Pages (from-to)39-44
Number of pages6
JournalWomen's Health Issues
Volume15
Issue number1
DOIs
StatePublished - Jan 1 2005

Fingerprint

Mifepristone
abortion
medication
Internal Medicine
Vacuum
medicine
resident
gynecology
trainee
Family Practice
Internship and Residency
Gynecology
Primary Health Care
Emotions
lack
Hemorrhage

ASJC Scopus subject areas

  • Health(social science)
  • Obstetrics and Gynecology
  • Public Health, Environmental and Occupational Health
  • Maternity and Midwifery

Cite this

Schwarz, E., Luetkemeyer, A., Foster, D. G., Weitz, T. A., Lindes, D., & Stewart, F. H. (2005). Willing and able? Provision of medication for abortion by future internists. Women's Health Issues, 15(1), 39-44. https://doi.org/10.1016/j.whi.2004.08.011

Willing and able? Provision of medication for abortion by future internists. / Schwarz, Eleanor; Luetkemeyer, Anne; Foster, Diana Greene; Weitz, Tracy A.; Lindes, Deborah; Stewart, Felicia H.

In: Women's Health Issues, Vol. 15, No. 1, 01.01.2005, p. 39-44.

Research output: Contribution to journalArticle

Schwarz, E, Luetkemeyer, A, Foster, DG, Weitz, TA, Lindes, D & Stewart, FH 2005, 'Willing and able? Provision of medication for abortion by future internists', Women's Health Issues, vol. 15, no. 1, pp. 39-44. https://doi.org/10.1016/j.whi.2004.08.011
Schwarz, Eleanor ; Luetkemeyer, Anne ; Foster, Diana Greene ; Weitz, Tracy A. ; Lindes, Deborah ; Stewart, Felicia H. / Willing and able? Provision of medication for abortion by future internists. In: Women's Health Issues. 2005 ; Vol. 15, No. 1. pp. 39-44.
@article{144b769f0ea94c048ae8f6002aacd8b0,
title = "Willing and able? Provision of medication for abortion by future internists",
abstract = "The development of medications such as mifepristone (RU486) has created the opportunity to introduce medication abortion as a component of office practice. Two hundred twelve residents training in internal medicine, family practice, and gynecology at 11 residency programs completed anonymous surveys assessing willingness to provide medication for abortion and perceived barriers to future provision of mifepristone. Residents training in internal medicine knew less about mifepristone and preabortion screening than other primary care trainees. Forty-two percent of internists, 84{\%} of family practitioners, and 83{\%} of gynecologists were willing to prescribe mifepristone (p < .001). Many internists were concerned about lacking adequate {"}backup{"} access to vacuum aspiration services (84{\%} of internists, 74{\%} of family practitioners, 35{\%} of gynecologists; p < .001). In multivariable analysis, the training-related factors most predictive of whether an internist was willing to provide medication for abortion were feeling that mifepristone is very safe, abortion services are needed by the patients served, knowing to check an ultrasound before inducing abortion, and having no concern of how to manage bleeding or of lacking adequate backup should vacuum aspiration be needed. Many (42{\%}) future internists are willing to provide mifepristone, but most lack adequate knowledge of mifepristone and preabortion screening. As access to abortion services is limited in many U.S. counties, internists who are willing to provide mifepristone should be offered the necessary training to do so safely.",
author = "Eleanor Schwarz and Anne Luetkemeyer and Foster, {Diana Greene} and Weitz, {Tracy A.} and Deborah Lindes and Stewart, {Felicia H.}",
year = "2005",
month = "1",
day = "1",
doi = "10.1016/j.whi.2004.08.011",
language = "English (US)",
volume = "15",
pages = "39--44",
journal = "Women's Health Issues",
issn = "1049-3867",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - Willing and able? Provision of medication for abortion by future internists

AU - Schwarz, Eleanor

AU - Luetkemeyer, Anne

AU - Foster, Diana Greene

AU - Weitz, Tracy A.

AU - Lindes, Deborah

AU - Stewart, Felicia H.

PY - 2005/1/1

Y1 - 2005/1/1

N2 - The development of medications such as mifepristone (RU486) has created the opportunity to introduce medication abortion as a component of office practice. Two hundred twelve residents training in internal medicine, family practice, and gynecology at 11 residency programs completed anonymous surveys assessing willingness to provide medication for abortion and perceived barriers to future provision of mifepristone. Residents training in internal medicine knew less about mifepristone and preabortion screening than other primary care trainees. Forty-two percent of internists, 84% of family practitioners, and 83% of gynecologists were willing to prescribe mifepristone (p < .001). Many internists were concerned about lacking adequate "backup" access to vacuum aspiration services (84% of internists, 74% of family practitioners, 35% of gynecologists; p < .001). In multivariable analysis, the training-related factors most predictive of whether an internist was willing to provide medication for abortion were feeling that mifepristone is very safe, abortion services are needed by the patients served, knowing to check an ultrasound before inducing abortion, and having no concern of how to manage bleeding or of lacking adequate backup should vacuum aspiration be needed. Many (42%) future internists are willing to provide mifepristone, but most lack adequate knowledge of mifepristone and preabortion screening. As access to abortion services is limited in many U.S. counties, internists who are willing to provide mifepristone should be offered the necessary training to do so safely.

AB - The development of medications such as mifepristone (RU486) has created the opportunity to introduce medication abortion as a component of office practice. Two hundred twelve residents training in internal medicine, family practice, and gynecology at 11 residency programs completed anonymous surveys assessing willingness to provide medication for abortion and perceived barriers to future provision of mifepristone. Residents training in internal medicine knew less about mifepristone and preabortion screening than other primary care trainees. Forty-two percent of internists, 84% of family practitioners, and 83% of gynecologists were willing to prescribe mifepristone (p < .001). Many internists were concerned about lacking adequate "backup" access to vacuum aspiration services (84% of internists, 74% of family practitioners, 35% of gynecologists; p < .001). In multivariable analysis, the training-related factors most predictive of whether an internist was willing to provide medication for abortion were feeling that mifepristone is very safe, abortion services are needed by the patients served, knowing to check an ultrasound before inducing abortion, and having no concern of how to manage bleeding or of lacking adequate backup should vacuum aspiration be needed. Many (42%) future internists are willing to provide mifepristone, but most lack adequate knowledge of mifepristone and preabortion screening. As access to abortion services is limited in many U.S. counties, internists who are willing to provide mifepristone should be offered the necessary training to do so safely.

UR - http://www.scopus.com/inward/record.url?scp=12344274313&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12344274313&partnerID=8YFLogxK

U2 - 10.1016/j.whi.2004.08.011

DO - 10.1016/j.whi.2004.08.011

M3 - Article

C2 - 15661586

AN - SCOPUS:12344274313

VL - 15

SP - 39

EP - 44

JO - Women's Health Issues

JF - Women's Health Issues

SN - 1049-3867

IS - 1

ER -